|
|
|
|
 |
|
SENSEX
|
 |
-456.53
|
-0.63%
|
|
71569.62
|
|
|
|
NIFTY
|
 |
-141.60
|
-0.65%
|
|
21569.20
|
|
|
|
Nasdaq
|
 |
13.77
|
0.09%
|
|
14524.07
|
|
|
|
Nikkei 225
|
 |
89.13
|
0.27%
|
|
33377.42
|
|
|
|
FTSE 100
|
 |
-33.50
|
-0.43%
|
|
7689.60
|
|
|
 |
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28-12-2023
|
|
|
|
| Themis Medicare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
|
|
|
|
28-12-2023
|
|
|
|
| THEMIS MEDICARE LIMITED has informed the Exchange about Closure of Trading Window |
|
|
|
|
|
27-12-2023
|
|
|
|
| Themis Medicare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
|
|
|
|
27-12-2023
|
|
|
|
| THEMIS MEDICARE LIMITED has informed the Exchange about Closure of Trading Window |
|
|
|
|
|
17-11-2023
|
|
|
|
| Themis Medicare Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. |
|
|
|
|
|
16-11-2023
|
|
|
|
| Themis Medicare Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. |
|
|
|
|
|
10-11-2023
|
|
|
|
| Themis Medicare Limited has informed the Exchange regarding a press release dated November 10, 2023, titled " Themis Medicare Launches REMITHEMï¿‚ï¾® REMIFENTANIL Injection A Novel Narcotic Analgesic for use during induction of anesthesia, during immed |
|
|
|
|
|
10-11-2023
|
|
|
|
| Themis Medicare Limited has informed the Exchange regarding a press release dated November 10, 2023, titled " Themis Medicare Launches REMITHEMï¿‚ï¾® REMIFENTANIL Injection A Novel Narcotic Analgesic for use during induction of anesthesia, during immediate post-operative period and in monitored anesthesia care .". |
|
|
|
|
|
09-11-2023
|
|
|
|
| Themis Medicare Limited has informed the Exchange about Transcript |
|
|
|
|
|
08-11-2023
|
|
|
|
| Themis Medicare Limited has informed the Exchange about Transcript |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|